Narwhal Capital Management Eli Lilly & CO Transaction History

Narwhal Capital Management

  • $1.09 Billion
  • Q4 2024

A detailed history of Narwhal Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Narwhal Capital Management holds 22,456 shares of LLY stock, worth $18.5 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
22,456
Previous 21,403 4.92%
Holding current value
$18.5 Million
Previous $19 Million 8.57%
% of portfolio
1.58%
Previous 1.73%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
BUY
$727.2 - $932.06 $765,741 - $981,459
1,053 Added 4.92%
22,456 $17.3 Million
Q3 2024

Oct 22, 2024
BUY
$772.14 - $960.02 $2.63 Million - $3.27 Million
3,407 Added 18.93%
21,403 $19 Million
Q2 2024

Aug 05, 2024
BUY
$724.87 - $909.04 $1.32 Million - $1.66 Million
1,821 Added 11.26%
17,996 $16.3 Million
Q1 2024

Apr 26, 2024
SELL
$592.2 - $792.28 $1.64 Million - $2.19 Million
-2,764 Reduced 14.59%
16,175 $12.6 Million
Q4 2023

Jan 24, 2024
SELL
$525.19 - $619.13 $331,920 - $391,290
-632 Reduced 3.23%
18,939 $11 Million
Q3 2023

Oct 27, 2023
SELL
$434.7 - $599.3 $1.09 Million - $1.5 Million
-2,500 Reduced 11.33%
19,571 $10.5 Million
Q2 2023

Aug 02, 2023
SELL
$350.74 - $468.98 $1.38 Million - $1.85 Million
-3,935 Reduced 15.13%
22,071 $10.4 Million
Q1 2023

May 01, 2023
BUY
$310.63 - $364.82 $1.76 Million - $2.07 Million
5,675 Added 27.91%
26,006 $8.93 Million
Q4 2022

Jan 30, 2023
BUY
$321.55 - $374.67 $1.01 Million - $1.17 Million
3,133 Added 18.22%
20,331 $7.44 Million
Q3 2022

Oct 31, 2022
BUY
$296.48 - $337.87 $4.84 Million - $5.52 Million
16,340 Added 1904.43%
17,198 $5.56 Million
Q1 2022

Apr 26, 2022
SELL
$234.69 - $291.66 $53,978 - $67,081
-230 Reduced 21.14%
858 $246,000
Q4 2021

Jan 26, 2022
SELL
$224.85 - $279.04 $34,626 - $42,972
-154 Reduced 12.4%
1,088 $301,000
Q2 2021

Jul 29, 2021
BUY
$180.55 - $233.54 $224,243 - $290,056
1,242 New
1,242 $285,000

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $783B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Narwhal Capital Management Portfolio

Follow Narwhal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email